TECHNOLOGY
EVŌQ, a Salt Lake City-based nanoscience company offering an antimicrobial nanoparticle platform across healthcare, textiles and beyond, has appointed Peter Barton Hutt to its board of directors. Hutt is widely recognized as the “Father of Modern Food and Drug Law” and has over six decades of food and drug law expertise. He currently is a retired partner-in-residence for Covington & Burling LLP. Hutt is a former U.S. Food and Drug Administration chief counsel. His accomplishments include creating the nutrition label format still used today, establishing cost-effective compliance tools, and drafting landmark legislation such as the Drug Listing Act and Medical Device Amendments. Throughout his career, he has represented major trade associations and guided countless companies through regulatory processes. His influence extends to academia, having taught food and drug law at Harvard Law School since 1994 and co-authored the leading casebook in the field.
